Clinical Decision Support Tool for Postpartum Depression

This study is testing a new computer tool called a Clinical Decision Support Tool. This tool uses artificial intelligence (AI) to help doctors identify pregnant women who might be at high risk for developing postpartum depression (PPD) after their baby is born. The tool will give doctors a risk score, tell them what factors might increase the risk, and suggest actions they can take, including ordering specific services. The study wants to see if this tool is easy for doctors to use and if it helps more women get the mental health care they need for PPD. You can join if you are 18 or older, are pregnant (20 weeks or more), and are seen at one of the participating clinics. The study is currently unclear about its recruitment status.

Study design
This is an interventional study with 160 planned participants. Some participants will receive usual care, while others will have their doctors use the Clinical Decision Support Tool.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study measures how well the tool is accepted, appropriate, and feasible one month and three months after its use begins.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06818734

Implementation of a Clinical Decision Support Tool for Postpartum Depression

Recruiting
NAAges 18+InterventionalSupportive care
Weill Medical College of Cornell University
~160 participants
Updated 2026-07-30 on ClinicalTrials.gov
What's tested:Clinical Decision Support Tool

At a glance

Recruiting sites
3 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Acceptability as measured by Unified Theory of Technology Acceptance Theory (UTAUT).
Measured over One month after initiation of tool use and three months after use.
+3 more outcomes measured
Postpartum Depression
4 sites across 1 states
New York4
  • Yiye Zhang, PhD · PRINCIPAL_INVESTIGATOR · Weill Medical College of Cornell University

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18 years or older
being seen at one of participating clinics
pregnancy at 20 week gestation or more

Exclusion

Does not speak inclusion
does not have internet access
If they manage patients in the three clinics as a board-certified OBGYN clinician.
  • Acceptability as measured by Unified Theory of Technology Acceptance Theory (UTAUT).One month after initiation of tool use and three months after use.

    UTAUT has five constructs: performance expectation, effort expectation, social influence, facilitating conditions, and behavioral intention. The performance expectation construct in UTAUT is the CDS's ability to identify patients at risk of PPD that clinicians agree with. For each construct, responses will be sought in the 7-point Likert scale, setting 1 as 'strongly disagree', 2 as 'disagree', to 7 as 'strongly agree'. We will average the acceptability survey responses at the end of the study for each of the 5 UTAUT constructs to create a binary variable. An average score of 5 or above will be considered acceptance and non-acceptance otherwise

  • Appropriateness as measured by Appropriateness Measure (IAM).One month after initiation of tool use and three months after use.

    IAM is a 4-item measure to assess the appropriateness of the intervention, respectively, with excellent usability. IAM is to be answered by participants in 5-point response scale: 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree.

  • Feasibility as measured by Feasibility of Intervention Measure (FIM).One month after initiation of tool use and three months after use.

    FIM is a 4-item measure to assess the feasibility of the intervention, respectively, with excellent usability. FIM is to be answered by participants in 5-point response scale: 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree.

  • Mental Health service utilization as measured by number of mental health visitsone month and three month

    Mental health service utilization includes presentations to ED or inpatient admission for mental health related reasons.